Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Poly(I:C) | 2 | ug/mL | 4 | MMP-3 | 258.0 | 45 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | MMP-3 | 37.0 | 41 | |
N2645 | Poly(I:C) | 2 | ug/mL | 4 | MMP-3 | 84.5 | 54 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | MMP-3 | 2601.5 | 34 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 4 | MMP-3 | 3013.5 | 36 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-3 | 79.5 | 52 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-3 | 128.5 | 56 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-3 | 43.0 | 64 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-3 | 204.0 | 60 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-3 | 297.5 | 50 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-3 | 6898.0 | 59 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-3 | 5006.0 | 49 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | MMP-3 | 3155.0 | 49 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-3 | 1670.0 | 53 | |
N2645 | IL-1 alpha | 100 | ng/mL | 4 | MMP-3 | 1540.5 | 52 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-3 | 25730.0 | 47 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 4 | MMP-3 | 39153.0 | 47 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MMP-3 | 77.0 | 49 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MMP-3 | 109.0 | 77 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MMP-3 | 45.0 | 61 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MMP-3 | 56.5 | 50 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MMP-3 | 383.0 | 39 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MMP-3 | 2167.0 | 66 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MMP-3 | 169.0 | 55 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | MMP-3 | 263.0 | 44 |